These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37005486)

  • 41. Preliminary investigation of mammographic density among women in Riyadh: association with breast cancer risk factors and implications for screening practices.
    Albeshan SM; Hossain SZ; Mackey MG; Peat JK; Al Tahan FM; Brennan PC
    Clin Imaging; 2019; 54():138-147. PubMed ID: 30639525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simplified Breast Risk Tool Integrating Questionnaire Risk Factors, Mammographic Density, and Polygenic Risk Score: Development and Validation.
    Rosner B; Tamimi RM; Kraft P; Gao C; Mu Y; Scott C; Winham SJ; Vachon CM; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):600-607. PubMed ID: 33277321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomised trial of weekend and evening breast screening appointments.
    Offman J; Wilson M; Lamont M; Birke H; Kutt E; Marriage S; Loughrey Y; Hudson S; Hartley A; Smith J; Eckersley B; Dungey F; Parmar D; Patnick J; Duffy SW
    Br J Cancer; 2013 Aug; 109(3):597-602. PubMed ID: 23867998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial.
    Moss SM; Cuckle H; Evans A; Johns L; Waller M; Bobrow L;
    Lancet; 2006 Dec; 368(9552):2053-60. PubMed ID: 17161727
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk-based breast cancer screening strategies in women.
    Harkness EF; Astley SM; Evans DG
    Best Pract Res Clin Obstet Gynaecol; 2020 May; 65():3-17. PubMed ID: 31848103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of number of views and mammographic film density on the detection of invasive cancers: results from the NHS Breast Screening Programme.
    Young KC; Wallis MG; Blanks RG; Moss SM
    Br J Radiol; 1997 May; 70(833):482-8. PubMed ID: 9227229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
    Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA;
    Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
    Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
    Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Digital breast tomosynthesis compared to diagnostic mammographic projections (including magnification) among women recalled at screening mammography: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).
    Canelo-Aybar C; Carrera L; Beltrán J; Posso M; Rigau D; Lebeau A; Gräwingholt A; Castells X; Langendam M; Pérez E; Giorgi Rossi P; Van Engen R; Parmelli E; Saz-Parkinson Z; Alonso-Coello P
    Cancer Med; 2021 Apr; 10(7):2191-2204. PubMed ID: 33675147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
    Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
    J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The acceptability of addressing alcohol consumption as a modifiable risk factor for breast cancer: a mixed method study within breast screening services and symptomatic breast clinics.
    Sinclair J; McCann M; Sheldon E; Gordon I; Brierley-Jones L; Copson E
    BMJ Open; 2019 Jun; 9(6):e027371. PubMed ID: 31209091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The introduction of risk stratified screening into the NHS breast screening Programme: views from British-Pakistani women.
    Woof VG; Ruane H; French DP; Ulph F; Qureshi N; Khan N; Evans DG; Donnelly LS
    BMC Cancer; 2020 May; 20(1):452. PubMed ID: 32434564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Breast cancer risk stratification for mammographic screening: A nation-wide screening cohort of 24,431 women in Singapore.
    Ho PJ; Wong FY; Chay WY; Lim EH; Lim ZL; Chia KS; Hartman M; Li J
    Cancer Med; 2021 Nov; 10(22):8182-8191. PubMed ID: 34708579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mammographic non-dense area and breast cancer risk in postmenopausal women: a causal inference approach in a case-control study.
    Velásquez García HA; Sobolev BG; Gotay CC; Wilson CM; Lohrisch CA; Lai AS; Aronson KJ; Spinelli JJ
    Breast Cancer Res Treat; 2018 Jul; 170(1):159-168. PubMed ID: 29516373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized controlled trial of mammographic screening from age 40 ('Age' trial): patterns of screening attendance.
    Johns LE; Moss SM;
    J Med Screen; 2010; 17(1):37-43. PubMed ID: 20356944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
    Abdolell M; Payne JI; Caines J; Tsuruda K; Barnes PJ; Talbot PJ; Tong O; Brown P; Rivers-Bowerman M; Iles S
    Eur Radiol; 2020 Oct; 30(10):5417-5426. PubMed ID: 32358648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Breast cancer risk status influences uptake, retention and efficacy of a weight loss programme amongst breast cancer screening attendees: two randomised controlled feasibility trials.
    Harvie M; Pegington M; French D; Cooper G; McDiarmid S; Howell A; Donnelly L; Ruane H; Sellers K; Foden P; Evans DG
    BMC Cancer; 2019 Dec; 19(1):1089. PubMed ID: 31795966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distribution of Estimated Lifetime Breast Cancer Risk Among Women Undergoing Screening Mammography.
    Niell BL; Augusto B; McIntyre M; Conley CC; Gerke T; Roetzheim R; Garcia J; Vadaparampil ST
    AJR Am J Roentgenol; 2021 Jul; 217(1):48-55. PubMed ID: 33978450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.